Segall Bryant & Hamill’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,714
Closed -$12.9M 589
2025
Q3
$12.9M Sell
28,714
-6,523
-19% -$2.95M 0.17% 198
2025
Q2
$17.2M Buy
35,237
+2,281
+7% +$1.3M 0.24% 143
2025
Q1
$20.3M Buy
32,956
+8,645
+36% +$4.91M 0.31% 103
2024
Q4
$12.9M Buy
+24,311
New +$13.7M 0.18% 173
2024
Q2
Sell
-12,815
Closed -$8.23M 413
2024
Q1
$8.23M Sell
12,815
-804
-6% -$488K 0.15% 221
2023
Q4
$7.96M Buy
13,619
+2,246
+20% +$1.26M 0.15% 218
2023
Q3
$5.91M Sell
11,373
-1,296
-10% -$674K 0.07% 301
2023
Q2
$6.86M Buy
12,669
+192
+2% +$105K 0.07% 295
2023
Q1
$6.71M Buy
12,477
+2,414
+24% +$1.23M 0.07% 296
2022
Q4
$5.14M Buy
10,063
+873
+9% +$425K 0.06% 320
2022
Q3
$4.01M Sell
9,190
-1,066
-10% -$513K 0.05% 348
2022
Q2
$4.81M Buy
+10,256
New +$5M 0.05% 323

Other funds holding CHE

Segall Bryant & Hamill's CHE Position: Q4 2025 in Review

Segall Bryant & Hamill sold out of Chemed (CHE) in Q4 2025, closing a stake of 28,714 shares — an estimated $12.9M sold.

Segall Bryant & Hamill first reported a position in CHE in Q2 2022 and held it in 12 quarters. The position peaked at $20.3M in Q1 2025. 516 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • Segall Bryant & Hamill reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
  • Segall Bryant & Hamill sold 28,714 Chemed shares in Q4 2025, an estimated $12.9M.
  • Segall Bryant & Hamill first reported a position in Chemed in Q2 2022 and held it in 12 quarters.
  • Segall Bryant & Hamill's Chemed position peaked at $20.3M in Q1 2025.
  • 516 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Segall Bryant & Hamill's 13F filing for Q4 2025, filed 13 Feb 2026.